(Q34407754)

English

Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

based on heuristic

inferred from title

open-angle glaucoma

1 reference

based on heuristic

inferred from title

author name string

Patel SS

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Spencer CM

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

1 November 1996

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

363-378

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

https://scigraph.springernature.com/pub.10.2165/00002512-199609050-00007

0 references

Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin F2 alpha-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Corneal permeability to and ocular metabolism of phenyl substituted prostaglandin esters in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conventional and uveo-scleral drainage of aqueous humour in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of the prostaglandin-induced reduction of intraocular pressure in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Another blockbuster glaucoma drug?

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2 alpha analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintained intraocular pressure reduction with once-a-day application of a new prostaglandin F2 alpha analogue (PhXA41). An in-hospital, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicted outcome from hypotensive therapy for glaucomatous optic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Latanoprost--a promising new glaucoma drug

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy of PhXA34 and PhXA41, two novel prostaglandin F2 alpha-isopropyl ester analogues for glaucoma treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morphological changes in primate aqueous humor formation and drainage tissues after long-term treatment with antiglaucomatous drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence of glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glaucoma: early detection and therapy for prevention of vision loss.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of manifest glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-angle glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular effects of two different prostaglandin F2 alpha esters. A doublemasked cross-over study on normotensive eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sexual dysfunction secondary to topical ophthalmic timolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of PhXA41, a prostaglandin analogue, and PGF2 alpha on the corneal and intraretinal d.c. electroretinogram (ERG) of the albino rabbit eye

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Derivatives of 17-phenyl-18,19,20-trinorprostaglandin F2 alpha isopropyl ester: potential antiglaucoma agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for open-angle glaucoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption of ocular timolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of prostaglandin F2 alpha on intraocular pressure in normotensive human subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of topically applied PGF2 alpha and its isopropylester on normal and glaucomatous human eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Economic Burden of Glaucoma in the UK

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The short-time effect of latanoprost on the intraocular pressure in normal pressure glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular hypotensive effect of PhXA41 in patients with ocular hypertension or primary open-angle glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of prostaglandin F2 alpha in the human eye

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Organic impotence associated with carbonic anhydrase inhibitor therapy for glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin F2 alpha-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandins as ocular hypotensive agents; development of an analogue for glaucoma treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of prostaglandin D2 and its analogue, BW245C, on intraocular pressure in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of glaucoma. The Beaver Dam Eye Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8922563

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002512-199609050-00007

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34407754&oldid=1976078655"